Researchers in the Stanford University Power Electronics Research Lab have designed an easy to implement, high-efficiency, high-frequency power amplifier with low voltage stress.
Stanford scientists have invented an inexpensive device to detect the first signs of lithium plating during fast-charging of lithium ion batteries, enabling early onboard detection of this issue during battery development or use.
As of 2020, radiation therapy has saved over 3.38 million cancer patients in the US. Radiation therapy treatment planning often involves a time-consuming and labor-intensive process where physicians must manually optimize the prescribed radiation dose.
A Stanford University physician has developed a device to stimulate regeneration of olfactory nerves using minimally invasive electrical neurostimulation.
Researchers at Stanford have developed methods for evaluating the position of a micro-electromechanical system (MEMS) device in terms of phase and/or amplitude characteristics.
Researchers in the Stanford Robotics Lab have developed a compact high-fidelity haptic teleoperation system which shows accurate and isotropic behavior in translation and rotation.
This invention involved a new methodology using novel targets, TMS stimulation and a hypnosis protocol to modulate traits and help chronic pain, addiction, and mental disorders.
Doctors with Stanford Medicine have developed a multi-user, mixed reality medical simulation application. Medical in-situ and simulation training centers cost millions of dollars a year to administer, with limited availability to those in remote areas or the third world.
Researchers at Stanford are advancing a new class of nonlinear optical devices that operate with significantly lower energy requirements than previous platforms.
Researchers in the Nakauchi lab at Stanford University have shown that the contribution of human donor cells to tissues and organs can be increased in an interspecies host embryo by knocking out insulin growth factor 1 receptor (Igf1r).
Stanford researchers are developing an improved prophylactic against pancreatitis caused by endoscopic retrograde cholangiopancreatography (ERCP), by targeting two key inflammatory pathways.
Stanford researchers have applied large-scale proteomic platforms to identify biomarkers that can be used to diagnose uveal melanoma and subtype eye tumors according to their gene expression profile (GEP) class or PRAME status.